NCT02916914 is a NA clinical trial of Q2 feeding in Bottlefeeding, sponsored by Etlik Zubeyde Hanim Womens' Health and Teaching Hospital.

Who is sponsoring NCT02916914?

NCT02916914 is sponsored by Etlik Zubeyde Hanim Womens' Health and Teaching Hospital.

What drugs are being tested in NCT02916914?

Interventions in NCT02916914: Q2 feeding.

What condition does NCT02916914 study?

NCT02916914 studies Bottlefeeding, Infant, Premature, Diseases.

Is NCT02916914 still recruiting?

NCT02916914 is currently completed. Last updated 16 August 2017.

Last reviewed 2017-08-16 · How we verify

NCT02916914

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Feeding Interval of Preterms on the Time of Transition From Tube Feeding to Oral Feeding

Completed NA Last updated 16 August 2017

What this trial tests

NA trial testing Q2 feeding in Bottlefeeding in 80 participants. Completed in 1 August 2017.

Timeline

30 September 2016

Primary endpoint
31 May 2017

1 August 2017

Quick facts

Lead sponsor	Etlik Zubeyde Hanim Womens' Health and Teaching Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	80
Start date	30 September 2016
Primary completion	31 May 2017
Estimated completion	1 August 2017
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Q2 feeding

Conditions studied

Bottlefeeding — all drugs for Bottlefeeding →
Infant, Premature, Diseases — all drugs for Infant, Premature, Diseases →

Sponsor

Etlik Zubeyde Hanim Womens' Health and Teaching Hospital

Who can join

Adults 7 Days to 90 Days, any sex, with Bottlefeeding or Infant, Premature, Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Preterms are usually fed with intervals of either two or three hours during their stay in neonatal intensive care unit. Recommendations of World Health Organization about feeding regimens, 3-hourly for infants 1500 - 2000 gr, and 2-hourly for infants 1000 - 1500 gr, are not proposed with regards to results of randomized controlled trials. Investigators aimed to investigate the impact of 2-hourly feeding on time of transition from orogastric to oral feeding.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02916914 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Etlik Zubeyde Hanim Womens' Health and Teaching Hospital
Last refreshed: 16 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02916914.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing